CIBC Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
VPM
VCM
EC
CIBC Asset Management's JAZZ Position: Q1 2026 in Review
CIBC Asset Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 1,999 shares worth $378K. The position accounts for ﹤0.01% of the portfolio, ranked #884.
CIBC Asset Management first reported a position in JAZZ in Q1 2014 and has held it in 18 quarters since. The position peaked at $17.1M in Q3 2014. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- CIBC Asset Management held 1,999 shares of Jazz Pharmaceuticals worth $378K as of Q1 2026.
- CIBC Asset Management left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
- Jazz Pharmaceuticals made up ﹤0.01% of CIBC Asset Management's portfolio in Q1 2026, its #884 holding.
- CIBC Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 18 quarters since.
- CIBC Asset Management's Jazz Pharmaceuticals position peaked at $17.1M in Q3 2014.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on CIBC Asset Management's 13F filing for Q1 2026, filed 12 May 2026.